Pharmaceuticals
We want to change the way iron deficiency is prevented and treated and have brought to market innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.
In recent years, Pharmacosmos has conducted more than 25 clinical trials across a range of disease areas affected by iron deficiency anaemia, including chronic kidney disease, inflammatory bowel disease, cardiac surgery, and a number of other populations.
A global pioneer in the chemistry of carbohydrates and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.